EMA Recommends Marketing Authorization for Pfizer-BioNTech’s Omicron-Adapted Covid-19 Vaccine
In a major development, Pfizer and BioNTech's Omicron adapted vaccine is one step closer to becoming available across the...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
In a major development, Pfizer and BioNTech's Omicron adapted vaccine is one step closer to becoming available across the...
Moderna's stock surges 4.5% to $72.28 after Canada approves its updated COVID-19 vaccine targeting the KP.2 variant, making it...
Moderna announces a 20% cut in research and development spending, aiming to stretch its cash reserves as vaccine sales...
Novavax's Covid-19 vaccine receives emergency-use authorization from the FDA, sending shares soaring 9% to $12.40 per share; this follows...
BioNTech's stock dropped 3.4% as second-quarter earnings missed estimates due to decreased COVID-19 vaccine sales. The company reported a...
Moderna's stock plunged 21%, erasing its gains for the year, after the biotech company cut its sales guidance for...
In a bid to regain ground lost during the pandemic, GlaxoSmithKline (GSK) has struck a deal with CureVac to...
In a shocking turn of events, Kansas has taken legal action against pharmaceutical giant Pfizer, claiming the company misled...
In a major development, Novavax announced it expects to deliver a Covid-19 vaccine targeting the recommended strain by September....
In a tragic helicopter crash, Iran's President Ebrahim Raisi has died, leading to Iran's first Vice President Mohammad Mokhber...